Results 91 to 100 of about 13,138 (168)

Fenofibrate plus statin and ASCVD risk by triglyceride-rich lipoprotein cholesterol in 70,000 patients. [PDF]

open access: yesJ Lipid Res
Jang Y   +6 more
europepmc   +1 more source

Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial.

open access: yesHealth Technol Assess
Preiss D   +16 more
europepmc   +1 more source

Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression. [PDF]

open access: yesJ Diabetes
O'Brien RC   +9 more
europepmc   +1 more source

Importance and Management of Non-High-Density Lipoprotein Cholesterol in Dyslipidemia Treatment. [PDF]

open access: yesJACC Asia
O'Brien RC   +11 more
europepmc   +1 more source

A case of lipoprotein glomerulopathy in which complete remission was achieved by pemafibrate therapy. [PDF]

open access: yesCEN Case Rep
Tomita C   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy